Hyperpigmentations, such as senile lentigo, melasma, freckles and pigmented acne scars, are of serious concern to women. Their treatment usually involves the use of medicines or medicinal cosmetics containing depigmenting agents or skin-whitening agents. For example, hydroquinone and 4-methoxyphenol are used as topical therapies for hyperpigmentation disorders. Active ingredients available for medicated whitening cosmetics in Japan include vitamin C and its stabilized phosphate 1) and glucoside derivatives, 2) kojic acid, 3) arbutin, 4) linoleic acid, 5) tranexamic acid, 6) 3-O-ethyl ascorbic acid 7) and ellagic acid. 8) Among them, kojic acid, arbutin, linoleic acid and ellagic acid are plant products. Kojic acid is a naturally occurring fungal metabolite produced from Asperigillus orzae. Arbutin is a naturally occurring glucosylated hydroquinone found in leaves of Arctostaphylos uva-ursi. Linoleic acid is contained in oilseed of Carthamus tinctorius and Helianthus annuus. Ellagic acid is contained in the shell of Caesalpinia spinosa fruits. These compounds inhibit the formation of melanin pigment by inhibiting the activity of tyrosinase, which is a key enzyme in melanin biosynthesis. Other tyrosinase inhibitors have been isolated from Morus alba L. (Moraceae), 9) Machilus thunbergii (Lauraceae), 10) Trichosanthes kirilowii (Cucurbitaceae), 11) Piper longum (Piperaceae) 12) and Artocarpus heterophyllus (Moraceae). 13) On the other hand, linoleic acid, which is formed as a secondary metabolite in various plants, inhibits the formation of melanin pigment without inhibiting tyrosinase activity. 5) Among the plant extracts we have studied, that of Arnica montana L. (Asteraceae) was also found to inhibit melanin accumulation without inhibiting tyrosinase activity. In this study, we isolated and identified the active compound, and investigated its mechanism of action.
MATERIALS AND METHODS
Materials a-Melanocyte-stimulating hormone (aMSH) was purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.). Eagle's minimum essential medium (MEM), fetal bovine serum, other tissue culture reagents, and SuperScript II RNaseH reverse transcriptase were purchased from Invitrogen (Carlsbad, CA, U.S.A.). 4-Methoxyphenol was purchased from Tokyo Kasei Kogyo (Tokyo, Japan). Arbutin was purchased from Nippon Seika (Osaka, Japan). Antimelanocyte-type isoform of microphthalmia-associated transcription factor (MITF) antibody (C5) was purchased from Labvision (Fremont, CA, U.S.A. Extraction and Isolation of Melanin Biosynthesis Inhibitor The active compound was extracted from the flowers of Arnica montana L., and isolated as follows (Fig. 1) . The dried flowers (5 kg) were extracted with a mixture of H 2 O and EtOH (20 : 80, 75 l) at 20 to 25°C for 7 d. After filtration, the solution was evaporated to dryness and the resulting extract was resuspended in H 2 O and extracted with EtOAc. Removal of the solvent from EtOAc phase gave an EtOAc-soluble residue (382 g). A part (124 g) of EtOAc-soluble residue was chromatographed on silica gel (750 g, silica gel G, Kantokagaku Pharmaceutical, Tokyo, Japan) and eluted with a step gradient of CHCl 3 -MeOH (1 : 0 to 0 : 1) to afford twelve fractions (A1-A12). The composition and volume of the eluent were as follows; A1-A4 (1 : 0, 1.0 l each), A5-A10 (10 : 1, 1.0 l each), A11 (8 : 2, 3.0 l) and A12 (0 : 1, 3.0 l). The fifth (A5) and sixth (A6) fractions were combined (7.6 g) and further chromatographed on silica gel (400 g, silica gel G, Kantokagaku Pharmaceutical) with a step gradient of n-hexane-EtOAc (10 : 1 to 0 : 1), and then the fractions were combined to afford twenty fractions (B1-B19) based on TLC. The composition and volume of the eluent were as follows; B1-B12 (10 : 1, total 22.0 l), B13 (10 : 1, 7.4 l), B14 (10 : 1, 3.8 l), B15-B17 (3 : 1, total 9.0 l) and B18-B19 (0 : 1, total 2.0 l). A part (100 mg) of the thirteenth fraction (B13, 805 mg) was subjected to HPLC (Shiseido Co., Ltd., Tokyo, Japan) with a linear gradient of 40% CH 3 CN-H 2 O (4 : 6 to 0 : 1) to afford nine fractions (C1-C9). The conditions were: flow rate 5 ml/min, column CAP-CELL PAK C18 (20 mmfϫ250 mm, Shiseido Co., Ltd., Tokyo, Japan), UV detection at 210 nm. The third fraction of the eluate was purified by HPLC under the same conditions. This was repeated until a single peak was obtained, finally affording 5.3 mg of white powder (compound [1] , yield 0.034%), which was used for the following experiment.
Determination C-NMR spectrum in CDCl 3 was measured to compare the literature of the taraxastane-type compounds. Furthermore, confirmation of the number and the position of the hydroxyl groups (having a exchangeable proton for CD 3 OD) were performed by measuring 13 C-NMR spectrum in CD 3 OD and CD 3 OH using a double-tube system.
Preparation of Test Samples for Monitoring of Inhibitory Activity
The residue obtained by evaporation of each fraction was dissolved in dimethylsulfoxide (DMSO) at the concentration of 2%. The test sample was diluted in DMSO to the concentration to use for an examination, which was performed with final concentration of DMSO as 0.1%. Control was added only 0.1% DMSO.
Cell Culture and Inhibition Assay Mouse B16 melanoma cells were cultured in Eagle's MEM containing FBS (10%) in 75 cm 2 flasks in a CO 2 incubator. The cells were released from the bottom of the flask with trypsin solution, suspended in Eagle's MEM containing FBS (10%) was added, and collected by centrifugation at 1100 rpm. The cells were seeded at 300000 cells per 100ϫ20 mm dish and cultured for one day in Eagle's MEM medium containing FBS (10%). For melanin biosynthesis inhibition assay, cells were cultured continuously in Eagle's MEM medium containing FBS (10%) and aMSH (10 ng/ml) (experimental medium) for 3 d in the presence of an appropriate concentration of a test sample, or 4-methoxyphenol or arbutin as a positive control. The amount of melanin per cell was then measured as follows.
Measurement of the Amount of Melanin The cells
were removed from the bottom of the dish with trypsin solution, and the solution containing the cells was transferred to a centrifuge tube. The dish was washed with PBS, and the washing was also transferred to the same centrifuge tube. The cells were counted with a Coulter Counter Z1 (Beckman Coulter, Fullerton, CA, U.S.A.), then collected by centrifugation at 1100 rpm. The pellets were air-dried, and 2 M NaOH solution was added to adjust the concentration to 10000 cells per 100 ml. This suspension was stirred at 60°C for 3 min to dissolve melanin, then a 50 ml aliquot was taken and diluted with 150 ml of water. The absorbance of the diluted sample at 500 nm was measured with a microplate reader (Powerscan HT). The inhibition rate (%) was calculated with respect to the control without addition of the compound [1] . The inhibitions of melanin synthesis and cell growth were performed by three determinations. Assay of Inhibitory Activity towards Tyrosinase B16 melanoma cells were stirred in 1% Triton-X 100 phosphatebuffered saline (PBS) solution at 4°C for 2 h, then the sample solution was centrifuged at 10000 rpm. The supernatant was filtered through an Amicon Ultra-15 filter (Millipore, Bedford, MA, U.S.A.) to afford the cell extract. The amount of proteins in this cell extract was measured with a micro BCA kit (Pierce, Rockford, IL, U.S.A.). Aliquots of 10 ml of the 0.5 mg/ml cell extract, 10 ml of 0.01 to 1 mM L-tyrosine or 0.01 to 1 mM L-b -3-(3,4-dihydroxyphenyl)alanine (L-DOPA), 10 ml of 0.002 to 2% active compound [1] , and 70 ml of PBS were placed in each well. A microplate reader was used in order to monitor the absorbance at 475 nm of red pigments synthesized from L-DOPA by tyrosinase. The inhibitory effect on tyrosinase activity was calculated from the absorbance ratio versus a control well that lacked the active compound.
Measurement of Cellular Tyrosinase Activity A mixture of 10 ml of the sample solution and 2 ml of glycerin was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The gel was soaked in PBS for 10 min, then solution was changed to PBS solution containing 0.2% L-DOPA. Soaking was continued with occasional exchange of the solution for 2 h at 37°C. The solution was removed and the gel was washed with PBS, then pictures of the gel were taken with a digital camera. The gel is dyed red to dark-brown at the location of tyrosinase protein, and the intensity of the band is proportional to the amount of tyrosinase activity.
Measurement of Protein Expression by Immunoblotting B16 melanoma cells were cultured in the experimental medium containing the active compound [1] . After 3 d of culture, the cells were collected with the aid of trypsin solution, and the number of cells was counted. The cells were lysed with a lysis buffer consisting of 62.5 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 50 mM DTT and 0.1% bromophenol blue. The lysates were boiled at 94°C for 5 min, and aliquots were subjected to 10% SDS-PAGE. After electrophoresis, proteins on the gel were electrophoretically transferred to PVDF membranes (Millipore, Bedford, MA, U.S.A.), which were treated with anti-tyrosinase, anti-tyrosinase-related protein-1 (TRP-1), anti-tyrosinase-related protein-2 (TRP-2), anti-PMEL17 antibodies [14] [15] [16] and anti-MITF antibody, followed by peroxidase-conjugated secondary antibody. Bands were reacted with Lumi-Light Western Blotting Substrate (Roche Diagnostica, Mannheim, Germany), and the chemiluminescence was measured with X ray film (Fuji Film, Tokyo, Japan).
Measurement of Expression of mRNA B16 melanoma cells were cultured in the experimental medium containing active compound [1] . After 3 d, total RNA was extracted with an RNeasy Micro Kit (QIAGEN, Tokyo, Japan) from the cultured cells. Total RNA in each extract was quantified and its purity was assessed by spectrophotometry using a ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE, U.S.A.). To synthesize the first-strand cDNA, DTT solution containing 50 ng of total RNA as template, 1 ml of oligo dT (50 mM) and 2 ml of 10 mM dNTP was incubated for 5 min at 65°C and then quickly put on ice for another 5 min. After addition of 4 ml of 5ϫfirst strand buffer, 1 ml of 0.1 M DTT, 40 U (in 1 ml) of RNase inhibitor (TaKaRa, Kyoto, Japan), and 1 ml of SuperScript II RnaseH reverse transcriptase, the reaction mixture was incubated for 90 min at 42°C, and then for 15 min at 70°C. LightCycler PCR was performed using a LightCycler RNA amplification kit with SYBR Green I (Roche Diagnostica). Primers for glyceraldehyde-3-phosphate dehydrogenase (Gapdh) were 5Ј-TGAACGGGAAGC-TCACTGG-3Ј and 5Ј-TCCACCACCCTGTTGCTGTA-3Ј. Primers for tyrosinase were 5Ј-TATTGAGCCTTACTTGG-AAC-3Ј and 5Ј-AAATAGGTCGAGTGAGGTAA-3Ј. Primers for Trp-1 were 5Ј-GCTGCAGGAGCCTTCTTTCTC-3Ј and 5Ј-AAGACGCTGCACTGCTGGTCT-3Ј. Primers for Trp-2 were 5Ј-CCTGGCCAAGAAGAGTATCC-3Ј and 5Ј-CACGT-CACACTCGTTCTTCC-3Ј. Primers for Pmel17 were 5Ј-TTGTTGTTGCTGGTCAAGACG-3Ј and 5Ј-GAAACTGA-GCCCTGCTTCTTA-3Ј. Primers for melanocyte-type isoform of microphthalmia-associated transcription factor (Mitfm) were 5Ј-CAGACATGCGGTGGAACAAG-3Ј and 5Ј-AAGTCCATGCGCTCTAGCCT-3Ј. After incubation at 95°C for 10 min, real-time PCR was performed under the following conditions: Gapdh; 95°C for 15 s, 62°C for 10 s, and 72°C for 12 s, tyrosinase, Trp-1, Trp-2; 95°C for 15 s, 55°C for 10 s, and 72°C for 12 s, Pmel17; 95°C for 15 s, 55°C for 5 s, and 72°C for 12 s, Mitf-m; 95°C for 15 s, 57°C for 10 s, and 72°C for 12 s. Each real-time PCR was performed in a total volume of 20 ml, containing diluted cDNA template, forward and reverse primers (each at a final concentration of 0.5 mM), and SYBR Green I master mix including Taq DNA polymerase, reaction buffer, and dNTP mix. Statistical Analyses In studies of cell growth and the expression of mRNA of compound [1] , Student's t-test was used to compare the means (Ϯstandard deviation) of the determinations.
RESULTS

Isolation of Active Compound and Structure Determination
A compound with melanin biosynthesis-inhibitory activity was isolated from the 80% ethanol extract of Arnica flowers by means of extraction with EtOAc/H 2 O, followed by silica gel column chromatography and HPLC, based on monitoring of the inhibitory activity of the eluates. The melanin inhibition by the 80% ethanol extract of Arnica flowers was observed at 0.125 mg/ml. The fractionation scheme and the melanin inhibitions of each fraction (B13, C1-C9) were shown in Fig. 1 C-NMR spectrum data (measured in CDCl 3 ) in the literature of the taraxastane-type compounds were shown in Fig. 2, i.e., 20(30)-taraxastene-3,16,21-triol (compound [a] ), 17) 20(30)-taraxastene-3b-ol21a-hydroperoxide (compound [b] ), 18) and 20(30)-taraxastene-3b,21a-diol (compound [c]) . 19, 20) The 13 C-NMR data showed that the compound [1] had three oxygenated carbon atoms (76.7, 79.0 and 84.5 ppm in CDCl 3 ) and the similar structure to these taraxastane-type compounds, especially compound [a] . The number and the position of the hydroxyl groups (having a exchangeable proton for CD 3 OH) were confirmed by analyzing the 13 C-NMR spectrum in CD 3 OD and CD 3 OH using a double-tube system (Fig. 3) . It was suggested that the carbon atoms at the 3-, 16-positions were connected to hydroxyl groups, but the carbon at the 21-position was not connected to hydroxyl group. The existence of hydroperoxy group in the compound [1] was confirmed by the chemical shift value of (Fig. 4) .
Inhibition of Melanin Biosynthesis by Compound [1]
3b,16b-Dihydroxy-21a-hydroperoxy-20(30)-taraxastene [1] inhibited melanin biosynthesis without affecting cell growth (Fig. 5) . Melanin accumulation was completely inhibited at 0.25 mg/ml (0.53 mM). The IC 50 value of this compound was 0.02 mg/ml (0.04 mM), while that of 4-methoxyphenol, a positive control, was 0.25 mg/ml (2.01 mM) (Fig. 6) . Thus, our compound is 50 times more potent than 4-methoxyphenol, a widely used depigmenting agent, and also much more potent than arbutin, which is used as a lightening ingredient in medicated cosmetics, at least in cell cultures.
Analysis of the Mechanism of Inhibition of Melanin Biosynthesis by Compound [1]
Compound [1] did not inhibit tyrosinase activity in the concentration range from 0.0625 mg/ml (0.13 mM) to 4 mg/ml (8.44 mM), using an enzyme solution prepared from B16 melanoma cells. So, we examined the cellular tyrosinase activity and the amount of tyrosinase protein in the cultured cells in the presence or absence of compound [1] . Tyrosinase activity in cultured cells was dose-dependently suppressed by compound [1] over the concentration range from 0.0625 mg/ml (0.13 mM) to 0.25 mg/ml (0.53 mM), in parallel with a decrease in the amount of tyrosinase protein (Fig. 7) . Other melanosomal proteins, TRP-1, TRP-2 and PMEL17, were also decreased by compound [1] in the same concentration range (Fig. 8) . Among The inhibitory effect on melanin accumulation was measured as the cellular melanin content after culture for 3 d in the presence of the compounds. Cellular melanin solubilized with 2 M NaOH was measured by absorbance at 500 nm using microplate reader. these melanogenic proteins, tyrosinase and TRP-1 were particularly inhibited by compound [1] , and the inhibition was essentially complete at 0.25 mg/ml. Next, we examined whether or not these proteins are transcriptionally regulated by compound [1] . The mRNA expression of these melanogenic proteins, TRP-1, TRP-2 and PMEL17, was inhibited in the presence of compound [1] and these inhibitions were statistically significant (Fig. 9) . As expression of these melanogenic proteins is regulated by the transcriptional factor MITF-M, the effect of the compound [1] on the expression of MITF-M protein was examined. The MITF-M protein was decreased by the compound [1] (Fig. 10) .
Effect of Similar Hydroperoxy Compound on Melanin Accumulation
We also examined the melanin biosynthesis-inhibitory effect of a similar compound containing a hydroperoxy group. As shown in Fig. 11, (2S,7S,13R ,14R,15S)-14-acetyl-14-hydroperoxy-2,13,15-trimethyltetracyclo [8.7.0.0 2, 7 .0 11, 15 ]heptadec-5-yl acetate (C 24 H 38 O 5 ) inhibited melanin accumulation at 0.5 mg/ml (1.23 mM), although it was less effective than compound [1] .
DISCUSSION
Arnica montana L. (Compositae) has been used as a folk medicine for the treatment of muscle sprain, stiffening, bruising, swelling and partial pain. The flower of this medicinal herb is known to have an anti-inflammatory effect, and the extract is used as an ointment and essential oil. We found that the flower contains a melanin biosynthesis inhibitor, which was isolated and identified as a traxastane-type triterpene, 3b,16b-dihydroxy-21a-hydroperoxy-20(30)-taraxastene [1] . And, the IC 50 of the compound [1] was as low as 0.04 mM. The melanin inhibition effect of compound [1] was not due to cytotoxicity, because the melanin assay was performed by adjusting the number of cells and the inhibition of cell growth was observed at the concentration of 0.25 mg/ml (0.53 mM). Several other melanin biosynthesis inhibitors that do not inhibit tyrosinase activity have been isolated from plants; these include 4,5-dihydroxy-3-propenyl-2-cyclopenten-1-one (terrein; IC 50 Լ30 mM) from Penicillium species, 21) piperlonguminine (IC 50 Լ10 mM) from Piper longum (Piperaceae), 12) and coumarin compounds such as soimperatorin and imperatorin (IC 50 Ͼ100 mM) from Angelica dahurica. 22) Thus, compound [1] is one of the most potent melanin Total RNA was extracted from cells were cultured for 1 d in medium containing 0.125 mg/ml of 3b,16b-dihydroxy-21a-hydroperoxy-20(30)-taraxastene [1] . The expression of mRNAs of tyrosinase, Trp-1, Trp-2 and Pmel17 was evaluated semi-quantitatively (meanϮstandard deviation, nϭ3). Data were normalized to Gapdh and divided by the respective normalized value of the control cells. * pϽ0.05. biosynthesis inhibitors so far isolated from plants. The characteristic of compound [1] is to have a hydroperoxy group at the 21-position of traxastane-type triterpene. Further study revealed that a similar hydroperoxy triterpene also suppressed the melanin pigment accumulation of B16 melanoma cells. These results indicate that the hydroperoxy group may play an important role in the suppression of the melanin accumulation by compound [1] .
Its mechanism of action was shown to involve inhibition of the expression of mRNAs of tyrosinase, Trp-1, Trp-2 and Pmel17. MITF-M is a transcription factor acting on the promoter in genes encoding many melanogenesis-relating proteins, including tyrosinase, TRP-1, TRP-2 and PMEL17. [23] [24] [25] [26] Therefore, it is reasonable to consider that compound [1] inhibits MITF-M, and consequently reduced expression of tyrosinase and related genes, and decreased protein levels of tyrosinase, TRP-1, TRP-2 and PMEL17. Tyrosinase, TRP-1 and TRP-2 are required for the melanin biosynthesis, a process critical to pigmentation. Compound [1] dramatically reduced tyrosinase, TRP-1 and TRP-2 accumulation, which would result in defects in melanin biosynthesis. PMEL17 is required for the formation of the fibrillar compartment in melanosome biogenesis. 27) Compound [1] also dramatically reduced PMEL17 accumulation, which would result in defects in melanosome biogenesis, as well as melanin synthesis, and thus decrease melanin accumulation in B16 melanoma cells.
